Latest News

Roche drug that previously failed in Covid-19 pneumonia shows efficacy in Phase III study

Actemra reduced the percentage of patients with Covid-19 pneumonia who progressed to requiring mechanical ventilation, but did not show an improvement in mortality, time to discharge or improvement on an ordinal scale of clinical status. Results of the Phase III COVACTA study, announced in July, were negative.

Source link

Related posts

Great minds may think alike, but all minds look alike


Improving outcomes after tonsillectomy


Severely Disabled People Mind-Control a Robotic Arm via EEG


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World